title: Dexmedetomidine: Superiority trials needed?
authors.affiliation: Anesthesiology/Critical Care, Hôpital Bichat, Paris, France. Electronic address: dan.longrois@aphp.fr.
authors.forename: D
authors.initials: D
authors.lastname: Longrois
authors.affiliation: Physiology, University of Lyon, Campus de la Doua, 8, rue R.-Dubois, 69622 Lyon-Villeurbanne cedex, France. Electronic address: lucquintin@yahoo.com.
authors.forename: L
authors.initials: L
authors.lastname: Quintin
mesh_terms: D058647:Adrenergic alpha-2 Receptor Agonists; D000070642:Brain Injuries, Traumatic / Q000150:complications / Q000628:therapy; D000075202:Contraindications; D003422:Critical Care; D054810:Deep Sedation / Q000379:methods; D020927:Dexmedetomidine; D006801:Humans; D006993:Hypnotics and Sedatives; D012128:Respiratory Distress Syndrome / Q000150:complications / Q000628:therapy
chemical_list: D058647:Adrenergic alpha-2 Receptor Agonists; D006993:Hypnotics and Sedatives; D020927:Dexmedetomidine
keywords: ARDS; Acute respiratory distress syndrome; Alpha-2 adrenergic agonists; Alpha-2 agonists; Clonidine; Critical care; Dexmedetomidine; Intracranial pressure; Sedation; Severe ARDS; Traumatic brain injury